FDA Urges Safe Use of Hyperbaric Oxygen Therapy Devices
Agency is reminding health care providers to carefully follow the manufacturer's instructions
High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma
Complete response rate was 37 percent, and post-hoc end point of objective response rate was 89 percent
Patient Perceptions of Physician Dress Depend on Setting
In emergency rooms and operating theaters, scrubs were consistently favored, but overall, the white coat still symbolizes professionalism
Lebrikizumab Efficacious, Safe for Patients With Skin of Color, Eczema
64.4 percent of patients with postinflammatory hyperpigmented lesions at baseline experienced reduced hyperpigmentation at week 24
Public Believes Dermatologic Side Effects From Cancer Treatment Are Common
Findings seen among both those previously treated for cancer and cancer-naive people
Firefighters Face Elevated Mortality Rates for Skin and Kidney Cancer
Suggestive increases for prostate and colorectal cancer mortality observed with more years as a firefighter
Novel Treatments Recommended for Management of Atopic Dermatitis in Adults
Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with concomitant topical therapy
Alopecia Areata Associated With Severe Psychosocial Impact
High levels of anxiety, depression, stigma, and impaired QoL reported by many patients; all linked to perceptions of illness
FDA Approves First Cream for Treating Chronic Hand Eczema
Study Compares Benefits, Harms of Treatments for Chronic Hives
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions
